A new study reports a commonly used NSAID anti-inflammatory drug was able to reverse memory loss in mouse models of Alzheimer's disease.
A newly developed antibody has shown to trigger a meaningful reduction of amyloid beta in patients with early stage Alzheimer's disease.
Researchers report that a commonly prescribed antidepressant may also protect against compounds that can cause memory loss and dementia.
Researchers have coupled machine learning with neuroimaging to detect early forms of dementia.
Alzheimer's risk is increased for those with anosognosia, a condition in which sufferers are unaware they are experiencing memory loss.
Researchers discover targeting the HDAC2 enzyme, by blocking its interaction with Sp3, resulted in the reversal of memory loss in mice. The findings, published in Cell Reports, may offer a new avenue for treating memory loss in Alzheimer's disease.
Blocking VCAM1 increased neurogenesis, and reduced microglia reactivity in the hippocampus of older mice.
A new study suggests that blood may hold clues to whether post-menopausal women may have an increased risk for brain damage that can lead to memory problems and an increased risk of stroke.
Decreased blood flow and blood oxygen levels to the hippocampus may explain symptoms of memory loss associated with Alzheimer's. Researchers say increasing hippocampal blood flow could reverse or protect against symptoms of the neurodegenerative disorder.
Researchers report boosting levels of osteocalcin in the blood may help reverse age related memory loss in mice.
Researchers find degeneration of the fornix can identify those at risk of cognitive decline long before clinical symptoms appear.
Researchers report the posterior cingulate plays a critical role in creating permanent, durable memories.
